Warning
Asclemed USA Inc. Recalls Lidocaine HCl Injection USP
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0659-2026Drug / Pharmaceutical
Asclemed USA Inc. Recalls Lidocaine HCl Injection USP
Asclemed USA Inc. · Class II — Moderate Risk
Product Description
Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 85766-187-01.
Reason for Recall
Lack of Assurance of Sterility
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
USA Nationwide
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
The FDA classified this recall as Class II, indicating the pharmaceutical product may cause temporary health problems or poses a slight threat of a serious nature. Asclemed USA Inc. initiated the recall on June 8, 2026. Lack of Assurance of Sterility. The product was distributed in USA Nationwide. Consumers should check their purchases and discontinue use of any affected product. Contact Asclemed USA Inc. for further instructions.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.